Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
ECS Trans ; 45(20)2013.
Artículo en Inglés | MEDLINE | ID: mdl-24396566

RESUMEN

Photodynamic inactivation of pathogenic bacteria and cancer cells by novel water-soluble decacationic fullerene monoadducts, C60[>M(C3N6+C3)2] and C70[>M(C3N6+C3)2], were investigated. In the presence of a high number of electron-donating iodide anions as parts of quaternary ammonium salts in the arm region, we found that C70[>M(C3N6+C3)2] produced more highly reactive HO• radical than C60[>M(C3N6+C3)2], in addition to singlet oxygen (1O2). This finding offers an explanation of the preferential killing of Gram-positive and Gram-negative bacteria by C60[>M(C3N6+C3)2] and C70[>M(C3N6+C3)2], respectively. The hypothesis is that 1O2 can diffuse more easily into porous cell walls of Gram-positive bacteria to reach sensitive sites, while the less permeable Gram-negative bacterial cell wall needs the more reactive HO• to cause real damage.

2.
Med Mycol ; 44 Suppl 1: S115-7, 2006 09.
Artículo en Inglés | MEDLINE | ID: mdl-17050430

RESUMEN

Invasive aspergillosis is characterized by two different types of angioinvasion. During pulmonary aspergillosis, hyphae are initially outside of the pulmonary vasculature and they invade the endothelial cell lining of the blood vessels by passing from the abluminal to the luminal surface. Some of these hyphal fragments can break off and circulate in the bloodstream. In severely immunocompromised hosts, these blood-borne hyphal fragments adhere to the luminal surface of the endothelial cells and they penetrate the endothelial cell lining of the vasculature by passing from the luminal to the abluminal surface. We have set up in vitro models of luminal and abluminal endothelial cell invasion by Aspergillus fumigatus. Luminal invasion by hyphae results in both endothelial cell damage and stimulation of tissue factor expression. Abluminal invasion causes less endothelial cell damage than luminal invasion, but greater induction of endothelial cells genes encoding cytokines, leukocyte adhesion molecules and tissue factor. These differences in the endothelial cell response to luminal versus abluminal infection may indicate significant differences in the pathogenesis of hematogenously disseminated versus locally invasive versus aspergillosis.


Asunto(s)
Aspergillus fumigatus/fisiología , Células Endoteliales/microbiología , Moléculas de Adhesión Celular/biosíntesis , Células Cultivadas , Citocinas/biosíntesis , Células Endoteliales/citología , Células Endoteliales/metabolismo , Humanos , Tromboplastina/biosíntesis
3.
Clin Microbiol Infect ; 12(4): 376-80, 2006 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-16524415

RESUMEN

Quantitative culture, quantitative PCR and the galactomannan enzyme immunoassay (EIA) were compared for their ability to determine the pulmonary fungal burden in a murine model of invasive aspergillosis. Quantitative culture of specimens containing hyphae under-represented the absolute fungal burden in established infection when compared with the two other methods. The best correlation was observed between the two non-culture methods. Higher variability was observed with the galactomannan EIA when compared with quantitative PCR. Collectively, these data suggest that quantitative PCR is the preferred method for determination of the pulmonary fungal burden in experimental aspergillosis.


Asunto(s)
Aspergilosis/microbiología , Aspergillus/aislamiento & purificación , Técnicas de Cultivo , Ensayo de Inmunoadsorción Enzimática , Enfermedades Pulmonares Fúngicas/microbiología , Reacción en Cadena de la Polimerasa , Animales , Pulmón/microbiología , Ratones
4.
Free Radic Biol Med ; 30(6): 643-9, 2001 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-11295362

RESUMEN

The effects of hexasulfobutylated C60 (FC4S), a free radical remover, on the total volume infarct size elicited by the damaging effects of focal cerebral ischemia were studied on Long-Evans rats in vivo. FC4S was administered intravenously either 15 min before middle cerebral artery (MCA) occlusion (pretreatment groups) or it was injected when the common carotid arteries clips were removed (treatment groups). FC4S did not alter the pH, blood gases, heart rate, or mean arterial blood pressure in either pretreatment or treatment groups of the rats. However, after administration of FC4S at dosages of 10 and 100 microg/kg, the total volume of infarction was significantly reduced in both pretreatment and treatment groups. In addition, after FC4S administration, the nitric oxide (NO) content in plasma was increased and the lactate dehydrogenase (LDH) levels was decreased. It is concluded that FC4S may be used as a neuroprotective agent on focal cerebral ischemia. The beneficial effects may be partly related to its antioxidant property and to the upregulation of NO production of the compound.


Asunto(s)
Isquemia Encefálica/tratamiento farmacológico , Carbono/uso terapéutico , Depuradores de Radicales Libres/uso terapéutico , Fulerenos , Fármacos Neuroprotectores/uso terapéutico , Animales , Antioxidantes/química , Antioxidantes/farmacología , Antioxidantes/uso terapéutico , Análisis de los Gases de la Sangre , Presión Sanguínea/efectos de los fármacos , Isquemia Encefálica/patología , Carbono/química , Carbono/farmacología , Arterias Carótidas/fisiología , Interpretación Estadística de Datos , Depuradores de Radicales Libres/química , Depuradores de Radicales Libres/farmacología , Frecuencia Cardíaca/efectos de los fármacos , Concentración de Iones de Hidrógeno , Infarto de la Arteria Cerebral Media/tratamiento farmacológico , Infarto de la Arteria Cerebral Media/patología , L-Lactato Deshidrogenasa/sangre , L-Lactato Deshidrogenasa/metabolismo , Masculino , Fármacos Neuroprotectores/química , Fármacos Neuroprotectores/farmacología , Óxido Nítrico/sangre , Óxido Nítrico/metabolismo , Ratas , Ratas Long-Evans , Reperfusión
5.
Toxicol Appl Pharmacol ; 171(3): 165-73, 2001 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-11243916

RESUMEN

We attempted to evaluate whether the antioxidants 1,3-dimethyl-2-thiourea (DMTU) and hexa(sulfobutyl)fullerenes (FC(4)S) attenuate monocrotaline (MCT)-induced pulmonary hypertension (PH) by lowering lung substance P (SP) in Wistar rats. Sixty-three rats weighing 297 +/- 8 g were divided into six groups: control; MCT; capsaicin + MCT; MCT + DMTU-1; MCT + DMTU-2; and MCT + FC(4)S. Three weeks before the functional study, saline was injected into each control rat, whereas each MCT rat received 60 mg/kg sc MCT. Rats in the third group received capsaicin pretreatment followed by MCT. A 3-day injection of DMTU was performed during the early (DMTU-1) or the late (DMTU-2) post-MCT period. For the last group, each MCT-treated rat received a daily FC(4)S injection until the commencement of the functional study. Compared to the control group, MCT caused significant increases in pulmonary arterial pressure (Ppa), right ventricular hypertropy, pulmonary arterial medial thickness, lung SP level, and luminol-enhanced chemiluminescence counts in bronchoalveolar lavage. Both capsaicin and antioxidants significantly attenuated the above MCT-induced alterations. SP-induced acute increase in Ppa was exaggerated in MCT-treated rats. These results suggest that oxygen radicals play an important role in MCT-induced PH via elevating lung SP level.


Asunto(s)
Hipertensión Pulmonar/metabolismo , Monocrotalina , Venenos , Especies Reactivas de Oxígeno/metabolismo , Sustancia P/metabolismo , Tiourea/análogos & derivados , Animales , Peso Corporal/efectos de los fármacos , Carbono/farmacología , Depuradores de Radicales Libres/farmacología , Hematócrito , Hipertensión Pulmonar/inducido químicamente , Hipertensión Pulmonar/fisiopatología , Técnicas para Inmunoenzimas , Mediciones Luminiscentes , Masculino , Músculo Liso Vascular/efectos de los fármacos , Arteria Pulmonar/efectos de los fármacos , Circulación Pulmonar/efectos de los fármacos , Ratas , Ratas Wistar , Tiourea/farmacología
6.
J Neurosci Res ; 62(4): 600-7, 2000 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-11070504

RESUMEN

Derivatives of C(60) have been shown to be effective free radical scavengers. Hence, many of the biological functions of fullerene are believed to be due to their antioxidant properties. Here we present evidence to show that fullerenols, that are caged fullerene oxides, exert their neuroprotective functions by blocking glutamate receptors and lowering the intracellular calcium, [Ca(2+)](i). In neuronal cultures, fullerenols reduce glutamate-induced neurotoxicity by about 80% at 50microM. No significant effect was observed on H(2)O(2)/Fe(2+)-induced neurotoxicity under the same conditions. Fullerenols were found to inhibit glutamate receptor binding in a dose-dependent manner inhibiting 50% of glutamate binding at 50 microM. Furthermore, AMPA receptors were found to be more sensitive to fullerenols than NMDA and KA receptors. On the other hand, GABA(A) receptors and taurine receptors were not significantly affected by fullerenols at the same concentrations used, suggesting that fullerenols inhibit primarily the glutamate receptors. In addition, fullerenols were also found to lower glutamate (Glu) receptor-induced elevation of [Ca(2+)](i), suggesting that the underlying mechanism of neuronal protective function of fullerenols is likely due to its ability to block the glutamate receptors and to reduce the level of [Ca(2+)](i).


Asunto(s)
Encéfalo/efectos de los fármacos , Carbono/farmacología , Antagonistas de Aminoácidos Excitadores/farmacología , Depuradores de Radicales Libres/farmacología , Fulerenos , Neuronas/efectos de los fármacos , Fármacos Neuroprotectores/farmacología , Receptores de Glutamato/efectos de los fármacos , Animales , Sitios de Unión/efectos de los fármacos , Sitios de Unión/fisiología , Encéfalo/citología , Encéfalo/metabolismo , Calcio/metabolismo , Muerte Celular/efectos de los fármacos , Muerte Celular/fisiología , Células Cultivadas/citología , Células Cultivadas/efectos de los fármacos , Células Cultivadas/metabolismo , Cloruros , Femenino , Compuestos Férricos/farmacología , Feto , Ácido Glutámico/farmacología , Peróxido de Hidrógeno/farmacología , Líquido Intracelular/efectos de los fármacos , Líquido Intracelular/metabolismo , Degeneración Nerviosa/inducido químicamente , Degeneración Nerviosa/tratamiento farmacológico , Degeneración Nerviosa/fisiopatología , Neuronas/citología , Neuronas/metabolismo , Embarazo , Ratas , Ratas Sprague-Dawley , Receptores de GABA/efectos de los fármacos , Receptores de GABA/metabolismo , Receptores de Glutamato/metabolismo , Receptores de Neurotransmisores/efectos de los fármacos , Receptores de Neurotransmisores/metabolismo
8.
Life Sci ; 66(16): 1525-33, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-10794500

RESUMEN

Amyloid beta protein (Abeta) alters signal transduction systems, including increases in the cytosolic free calcium ([Ca2+]i) response which have pathophysiological significance in Alzheimer's disease (AD). The purposes of this study were to elucidate the mechanism involved in Abeta's effect on the Ca2+ signal and to evaluate the effect of fullerenol-1, a water-soluble hydroxyl and superoxide radical scavenger, on the Abeta-induced Ca2+ response. Both Abeta and bradykinin (BK) dose-dependently elevated [Ca2+]i in PC12 cells. Fullerenol-1, at a concentration range between 100 nM and 1 microM, dose-dependently reduced the Abeta-induced [Ca2+]i response, but did not alter the subsequent BK-mediated process. Thapsigargin, an inhibitor of Ca2+-ATPase, released Ca2+ from the internal store and diminished the BK-mediated calcium spike but did not affect the Abeta-induced Ca2+ response. In the absence of extracellular calcium, the Abeta-induced, but not BK-induced, calcium spike was completely abolished. The Ca induced by Abeta did not enter through the voltage-dependent calcium channels or ligand gated calcium channels, because the peak of Abeta-evoked Ca2+ was not significantly altered by various Ca2+ channel blockers or a NMDA receptor antagonist MK801. In addition, neither cholera toxin nor pertussis toxin altered the Abeta-induced Ca response. The results demonstrated that Abeta-stimulated [Ca2+]i increase is due to Ca influx from an extracellular source rather than from the intracellular store. Alteration of the membrane lipid structure and permeability by free radicals generated by Abeta may be a major cause of Ca -influx. Furthermore, fullerenol-1, a novel antioxidant, may provide therapeutic benefits in neurodegenerative diseases such as AD.


Asunto(s)
Péptidos beta-Amiloides/antagonistas & inhibidores , Calcio/metabolismo , Carbono/farmacología , Depuradores de Radicales Libres/farmacología , Fulerenos , Fragmentos de Péptidos/farmacología , Animales , Cromanos/farmacología , Relación Dosis-Respuesta a Droga , Células PC12 , Piperazinas/farmacología , Ratas , Vitamina E/farmacología
9.
Proc Soc Exp Biol Med ; 224(2): 69-75, 2000 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10806413

RESUMEN

Oxidative modification of low-density lipoprotein (LDL) plays a pivotal role in the pathogenesis of atherosclerosis. Increasing the resistance of LDL to oxidation may therefore mitigate, or even prevent, atherosclerosis. A new water-soluble C60 derivative, hexasulfobutyl[60]fullerene [C60 - (CH2CH2CH2CH2-SO3Na)6; FC4S], consisting of 6 sulfobutyl moieties covalently bound onto the C60 cage is a potent free radical scavenger. This study explored the antioxidative effect of sulfobutylated fullerene derivatives (FC4S) on LDL oxidation. FC4S was found to be effective in protecting LDL against oxidation induced by either Cu2+ or azo peroxyl radicals generated initially in the aqueous or lipophilic phase, respectively. Levels of the oxidative products, conjugated diene and thiobarbituric acid-reactive substances, and the relative electrophoresis mobility of the LDL were decreased. The addition of 20 microM FC4S at the early stage of oxidation increased the kinetic lag time from 69 +/- 11 to 14 +/- 10 min (P < 0.05) and decreased the propagation rate from 17.1 +/- 2.6 to 6.3 +/- 1.0 mOD/min (P < 0. 005). Persistent suppression of peroxidation reaction was observed upon further addition of FC4S after full consumption of all endogenous antioxidants during the propagation period. Intravenous injection of hypercholesterolemic rabbits with FC4S (1 mg/kg/day) efficiently decreased atheroma formation. Data substantiate the use of FC4S as an excellent hydrophilic antioxidant in protecting atheroma formation, via removing free radicals, in either aqueous or lipophilic phase.


Asunto(s)
Carbono/farmacología , Fulerenos , Lipoproteínas LDL/metabolismo , Oxidación-Reducción/efectos de los fármacos , Animales , Arteriosclerosis/patología , Compuestos Azo/metabolismo , Carbono/efectos adversos , Electroforesis en Gel de Agar/métodos , Humanos , Peroxidación de Lípido , Masculino , Estructura Molecular , Nitrilos/metabolismo , Conejos , Solubilidad , Agua
10.
World J Surg ; 24(4): 450-4, 2000 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10706918

RESUMEN

Fullerenol, a water-soluble C(60)-fullerene derivative, has been demonstrated to have the capability to scavenge free radicals in vitro and in vivo. The purpose of this study was to investigate whether fullerenol can scavenge the free radicals that are massively induced during ischemia-reperfusion (I/R) injury of the small intestine, either preventively or therapeutically. Clamping the superior mesenteric artery and vein for 60 minutes to induce I/R injury was performed on male mongrel dogs. Thirty dogs were divided into three groups (10 in each): The control (C) group received no medication; the preventive (P) group received fullerenol (1 mg/kg) intravenously 30 minutes before ischemia; the therapeutic (T) group received the same dose of fullerenol immediately after reperfusion. This study was an experimental randomized trial. Intestinal segments were obtained 10, 20, 30, and 60 minutes after reperfusion; and blood samples and specimens of major organs were taken 60 minutes after reperfusion. Concentrations of lipid peroxidation products, including conjugated diene (CD) and malondialdehyde (MDA), and the level of glutathione (GSH) in intestinal tissue were determined. Serum indicators of liver and renal function were measured. Histologic examination of the small intestine and major organs were also performed. A significant increase in intestinal MDA and CD contents was detected at 30 and 60 minutes after reperfusion. The tissue GSH content, in contrast, was decreased 60 minutes after reperfusion. Administration of fullerenol diminished these changes both preventively and therapeutically. Liver and renal functions were within normal limits in all groups. Moreover no obvious histopathologic additional damage could be found in either the P or the T group. It is suggested that fullerenol can be considered a powerful scavenger for the free radicals induced by I/R injury of the small intestine.


Asunto(s)
Carbono/uso terapéutico , Depuradores de Radicales Libres/uso terapéutico , Fulerenos , Enfermedades Intestinales/prevención & control , Intestino Delgado/efectos de los fármacos , Daño por Reperfusión/prevención & control , Alanina Transaminasa/sangre , Fosfatasa Alcalina/sangre , Análisis de Varianza , Animales , Aspartato Aminotransferasas/sangre , Nitrógeno de la Urea Sanguínea , Carbono/administración & dosificación , Creatinina/sangre , Perros , Estudios de Seguimiento , Depuradores de Radicales Libres/administración & dosificación , Glutatión/análisis , Inyecciones Intravenosas , Enfermedades Intestinales/tratamiento farmacológico , Enfermedades Intestinales/metabolismo , Enfermedades Intestinales/patología , Intestino Delgado/irrigación sanguínea , Intestino Delgado/química , Intestino Delgado/patología , Isquemia/etiología , Peroxidación de Lípido , Masculino , Malondialdehído/análisis , Arteria Mesentérica Superior , Venas Mesentéricas , Premedicación , Distribución Aleatoria , Daño por Reperfusión/tratamiento farmacológico , Distribución Tisular
12.
Br J Pharmacol ; 126(3): 778-84, 1999 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10188991

RESUMEN

Antioxidants attenuate noncholinergic airway constriction. To further investigate the relationship between tachykinin-mediated airway constriction and oxygen radicals, we explored citric acid-induced bronchial constriction in 48 young Hartley strain guinea-pigs, divided into six groups: control; citric acid; hexa(sulphobutyl)fullerenes + citric acid; hexa(sulphobutyl)fullerenes + phosphoramidon + citric acid; dimethylthiourea (DMTU) + citric acid; and DMTU + phosphoramidon + citric acid. Hexa(sulphobutyl)fullerenes and DMTU are scavengers of oxygen radicals while phosphoramidon is an inhibitor of the major degradation enzyme for tachykinins. Animals were anaesthetized, paralyzed, and artificially ventilated. Each animal was given 50 breaths of 4 ml saline or citric acid aerosol. We measured dynamic respiratory compliance (Crs), forced expiratory volume in 0.1 (FEV0.1), and maximal expiratory flow at 30% total lung capacity (Vmax30) to evaluate the degree of airway constriction. Citric acid, but not saline, aerosol inhalation caused marked decreases in Crs, FEV0.1 and Vmax30, indicating marked airway constriction. This constriction was significantly attenuated by either hexa(sulphobutyl)fullerenes or by DMTU. In addition, phosphoramidon significantly reversed the attenuating action of hexa(sulphobutyl)fullerenes, but not that of DMTU. Citric acid aerosol inhalation caused increases in both lucigenin- and t-butyl hydroperoxide-initiated chemiluminescence counts, indicating citric acid-induced increase in oxygen radicals and decrease in antioxidants in bronchoalveolar lavage fluid. These alterations were significantly suppressed by either hexa(sulphobutyl)fullerenes or DMTU. An elastase inhibitor eglin-c also significantly attenuated citric acid-induced airway constriction, indicating the contributing role of elastase in this type of constriction. We conclude that both oxygen radicals and elastase play an important role in tachykinin-mediated, citric acid-induced airway constriction.


Asunto(s)
Broncoconstricción/efectos de los fármacos , Quelantes/farmacología , Ácido Cítrico/farmacología , Elastasa Pancreática/fisiología , Especies Reactivas de Oxígeno/fisiología , Animales , Peso Corporal/efectos de los fármacos , Líquido del Lavado Bronquioalveolar , Volumen Espiratorio Forzado/efectos de los fármacos , Depuradores de Radicales Libres/farmacología , Cobayas , Elastasa Pancreática/antagonistas & inhibidores , Ápice del Flujo Espiratorio/efectos de los fármacos , Proteínas , Pruebas de Función Respiratoria , Serpinas/farmacología , Tiourea/análogos & derivados , Tiourea/farmacología , Capacidad Vital/efectos de los fármacos , terc-Butilhidroperóxido/farmacología
13.
Br J Pharmacol ; 123(6): 1097-102, 1998 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-9559892

RESUMEN

1. The possible mechanisms of the antiproliferative effect of polyhydroxylated fullerene (fullerenol), a novel free radical trapper, were studied in rat vascular smooth muscle cells (A7r5 cells) and compared with the effect of ascorbic acid. 2. Fullerenol-1 and ascorbic acid inhibited the proliferative responses in a number of cells, including rat aortic smooth muscle cells (A7r5 cells), human coronary artery smooth muscle cells, and human CEM lymphocytes (CEM cells) in a concentration dependent manner. 3. At the concentration range of 10(-6) to 10(-2) M, fullerenol-1 and ascorbic acid concentration-dependently inhibited the proliferative responses stimulated by serum in A7r5 cells. Fullerenol-1 was more potent than ascorbic acid. 4. The production of O2- induced by alloxan, a diabetogenic compound, was reduced by fullerenol-1 (10(-4) M) in the presence of A7r5 cells. 5. The cytosolic protein kinase C activity of A7r5 cells stimulated by phorbol ester was reduced by 10(-3) M fullerenol-1, but not ascorbic acid (10(-4)-10(-2) M) and fullerenol-1 at lower concentrations (10(-6)-10(-4) M). 6. In contrast, the membraneous protein tyrosine kinase activity of A7r5 cells stimulated by foetal calf serum was significantly reduced by fullerenol-1 (10(-6)-10(-3) M) and ascorbic acid (10(-4)-10(-2) M). Again, the inhibitory activity of fullerenol-1 was greater than that of ascorbic acid. 7. Our results demonstrate that fullerenol-1 and ascorbic acid exhibit inhibitory effects on transduction signals in addition to their antioxidative property. It is suggested that the antiproliferative effect of fullerenol-1 on vascular smooth muscle cells may partly be mediated through the inhibition of protein tyrosine kinase.


Asunto(s)
Carbono/farmacología , Fulerenos , Músculo Liso Vascular/efectos de los fármacos , Animales , Ácido Ascórbico/farmacología , División Celular/efectos de los fármacos , Línea Celular , Activación Enzimática , Humanos , Músculo Liso Vascular/citología , Músculo Liso Vascular/enzimología , Proteína Quinasa C/metabolismo , Proteínas Tirosina Quinasas/metabolismo , Ratas , Superóxidos/metabolismo
14.
Toxicol Pathol ; 26(1): 143-51, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9502397

RESUMEN

Polyalkylsulfonated C60, or FC4S, a highly water-soluble caged fullerene derivative, is believed to be a free radical remover or an antioxidant in biological systems. A 50 mg/ml aqueous solution was prepared as a master solution and administered to female Sprague-Dawley CD(Crl:CD(SD)BR) rats in a single-dose acute toxicity study or a 12-day subacute toxicity study where rats were given the solution daily. In a study of the median lethal dose (LD50), no rats died after oral administration, and thus FC4S was considered to be nontoxic if administered orally. In an LD50 intraperitoneal injection study, rats died within 30 hr after injection; the LD50 was determined to be approximately 600 mg per kilogram of body weight. Rats injected with the compound intraperitoneally or intravenously immediately eliminated the compound through the kidney; the kidney appeared to be the primary target organ. The compound induced a distinct lysosome-overload nephrosis, a phagolysosomal nephropathy characterized by a tinctorial difference between the outer cortex and the inner cortex and the medulla. The affected outer cortex showed a diffuse degeneration, with the presence of numerous large vacuoles and cytoplasmic aggregates in the tubular epithelium. The phagolysosomal nephropathy was detected in rats after acute exposure as well as in the surviving rats following 1 intraperitoneal injection of 500 mg/kg or intravenous injection of 100 mg/kg. Ultrastructural investigation revealed numerous membranous conglomerates characteristic of phagolysosomal and/or lysosomal inclusions in the cytoplasm of the renal tubular epithelium. These conglomerates were confined to the vacuole, electron-dense, and unevenly stained. They varied in size and shape and were fused or aggregated. Occasional phagolysosomes were also observed in the endothelial cells of the peritubular plexus. A preliminary study of microsomal enzyme activity analysis revealed a suppression effect of liver cytochrome P-450-dependent monooxygenase activities, including cytochrome P-450, cytochrome b5, and benzo(a)pyrene hydroxylase, but an increased level of kidney cytochrome P-450-dependent monooxygenase activities, including NADPH-cytochrome P-450 reductase. The significance of these enzyme alterations was not well determined. Further study is needed to clarify the correlation between the alterations of microsomal enzyme activity and the nephropathy of lysosomal overload-induced changes. These changes may serve as a biological marker in toxicity screening tests for this class of compound.


Asunto(s)
Carbono/toxicidad , Depuradores de Radicales Libres/toxicidad , Fulerenos , Riñón/efectos de los fármacos , Lisosomas/efectos de los fármacos , Microsomas Hepáticos/efectos de los fármacos , Administración Oral , Animales , Peso Corporal/efectos de los fármacos , Femenino , Inyecciones Intraperitoneales , Inyecciones Intravenosas , Riñón/enzimología , Riñón/patología , Enfermedades Renales/inducido químicamente , Enfermedades Renales/patología , Dosificación Letal Mediana , Lisosomas/ultraestructura , Microsomas Hepáticos/enzimología , Necrosis , Tamaño de los Órganos/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Solubilidad
15.
J Auton Pharmacol ; 17(4): 229-235, 1997 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-9410871

RESUMEN

1. This study investigated the effects of increased antioxidants (administration of water-soluble fullerenol-1 and pre-exposure to chronic hypoxia) as well as an iron-chelating agent (deferoxamine) on exsanguination-induced noncholinergic airway constriction in guinea-pigs. 2. Fullerenol-1 usually did not cause significant alteration in respiratory function (lung volumes, dynamic respiratory compliance, maximal expiratory flow at 50% total lung capacity (Vmax50), and forced expiratory flow at 0.1 s (FEV 0.1) at low (200 micrograms kg-1) or at high doses (2 mg kg-1), except that it produced a slight bronchial constricting action (decreases in both Vmax 50 and FEV 0.1) at high doses (2 mg kg-1) via intratracheal instillation. 3. Beginning 15 min after exsanguination, there was a marked temporal decrease in FEV 0.1, indicating a gradual increase in airway constriction with time. 4. Administration of either fullerenol-1 or deferoxamine, or pre-exposure to chronic hypoxia significantly ameliorated the exsanguination-induced bronchoconstriction. The results provide evidence that oxygen radicals play an important role in exsanguination-induced airway constriction. 5. The significant effects of the increased antioxidants and deferoxamine,however, cannot be explained by the alteration in either tracheal neutral endopeptidase activity or lung tissue substance P level.


Asunto(s)
Antídotos/farmacología , Broncoconstricción/efectos de los fármacos , Carbono/farmacología , Deferoxamina/farmacología , Depuradores de Radicales Libres/farmacología , Fulerenos , Animales , Endopeptidasas/metabolismo , Volumen de Reserva Espiratoria/efectos de los fármacos , Cobayas , Hipoxia/fisiopatología , Masculino , Sistema Respiratorio/efectos de los fármacos , Sustancia P/metabolismo
16.
J Pharm Pharmacol ; 49(4): 438-45, 1997 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-9232545

RESUMEN

The role of polyhydroxylated C60 (fullerenol), a novel free-radical trapper, in prevention of hydrogen peroxide- and cumene hydroperoxide-elicited damage was studied in hippocampal slices from the rat in-vitro. The interactions of polyhydroxylated C60, adenosine and 6,7-dinitroquinoxaline-2,3-dione (DNQX) were also compared. Hydrogen peroxide (0.006-0.02%) and cumene hydroperoxide (0.5-1.0 mM) both reversibly reduced the amplitudes of CA1-evoked population spikes in the hippocampal slices. Deferoxamine (1 mM) had little effect on the population spikes. Deferoxamine (1 mM) significantly prevented the hydrogen peroxide (0.006%) elicited inhibition of the population spikes. Polyhydroxylated C60 (0.1 mM) significantly prevented hydrogen peroxide- or cumene hydroperoxide-elicited reduction of the population spikes and also prevented the effects of hydrogen peroxide and cumene hydroperoxide on paired-pulse facilitation in the hippocampal slice. Adenosine reduced the amplitude of population spikes and promoted paired-pulse facilitation in the CA1 region of the hippocampus. Polyhydroxylated C60 did not alter either of the effects of adenosine on the population spikes. DNQX reduced the amplitude of the population spikes in the CA1 region but did not affect the ratio of paired-pulse facilitation. Fullerenol did not alter either effect of DNQX on the population spikes. These results suggested that polyhydroxylated C60 prevented hydrogen peroxide- and cumene hydroperoxide-elicited damage in the hippocampuss slices. These effects might be associated with the free-radical scavenging activity of polyhydroxylated C60.


Asunto(s)
Derivados del Benceno/toxicidad , Carbono/farmacología , Depuradores de Radicales Libres/farmacología , Fulerenos , Hipocampo/efectos de los fármacos , Peróxido de Hidrógeno/toxicidad , Oxidantes/toxicidad , Adenosina/farmacología , Animales , Electrofisiología , Antagonistas de Aminoácidos Excitadores/farmacología , Radicales Libres , Hipocampo/patología , Hidroxilación , Masculino , Células Piramidales/citología , Células Piramidales/efectos de los fármacos , Quinoxalinas/farmacología , Ratas , Ratas Wistar , Vasodilatadores/farmacología
18.
Toxicol Lett ; 93(1): 29-37, 1997 Sep 19.
Artículo en Inglés | MEDLINE | ID: mdl-9381480

RESUMEN

The acute toxicity of fullerenol-1 was determined using mice pretreated intraperitoneally (i.p.) with polyhydroxylated C60 derivatives. The LD50 value of fullerenol-1 was estimated to be 1.2 g/kg. Pretreatments with 0.5 and 1.0 g/kg fullerenol-1 decreased cytochromes P450 and b5 contents, and NADPH-cytochrome P450 reductase, benzo[a]pyrene hydroxylase, 7-ethoxycoumarin O-deethylase, aniline hydroxylase, and erythromycin N-demethylase activities in liver microsomes. Pretreatments with 0.01 and 0.1 g/kg fullerenol-1 had no effect on these monooxygenases. Additions of fullerenol-1 to mouse liver microsomes suppressed monooxygenases activities toward benzo[a]pyrene, 7-ethoxycoumarin, aniline, and erythromycin with IC50 values of 42, 94, 102 and 349 microM, respectively. Fullerenol-1 exhibited noncompetitive and mixed-type of inhibition in benzo[a]pyrene hydroxylation and 7-ethoxycoumarin O-deethylation, respectively. Additions of fullerenol-1 to rat liver mitochondria resulted in a dose-dependent inhibition of ADP-induced uncoupling and markedly inhibited mitochondrial Mg2+ -ATPase activity with an IC50 value of 7.1 microM. These results demonstrate that fullerenol-1 can suppress the levels of the microsomal enzymes in vivo and decrease the activities of P450-dependent monooxygenase and mitochondrial oxidative phosphorylation in vitro.


Asunto(s)
Carbono/toxicidad , Inhibidores Enzimáticos del Citocromo P-450 , Depuradores de Radicales Libres/toxicidad , Fulerenos , Microsomas Hepáticos/efectos de los fármacos , Mitocondrias Hepáticas/efectos de los fármacos , Fosforilación Oxidativa/efectos de los fármacos , Animales , ATPasa de Ca(2+) y Mg(2+)/antagonistas & inhibidores , ATPasa de Ca(2+) y Mg(2+)/metabolismo , Sistema Enzimático del Citocromo P-450/metabolismo , Relación Dosis-Respuesta a Droga , Inhibidores Enzimáticos/toxicidad , Dosificación Letal Mediana , Masculino , Ratones , Ratones Endogámicos ICR , Microsomas Hepáticos/enzimología , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA